Recently, lipid-droplet accumulating microglia have emerged as a new potential biomarker for neurodegenerative diseases including AD; the accumulation of LDs is also believed to impair the microglial tau phagocytosis and exacerbate tau pathology4,8. This evidence concerns the gene MAPT and Alzheimer disease.